Sen. Jim Banks (R-Ind.) wants the Food and Drug Administration to look into foreign-made active pharmaceutical ingredients he ...
Japanese drug firm Chugai Pharmaceutical has established competitive advantages due to its alliance with majority shareholder Roche as well as its internal research and development engine. While ...
Charles C. Wykoff, MD, PhD, Retinal Consultants of Texas, spoke to the current state of research on revakinagene taroretcel ...
The FDA recently approved the first treatment in nearly 30 years for acute stroke, and the agency also approved a novel drug ...
Spectral Medical Inc. ("Spectral" or the "Company") (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic shock ...
TORONTO, March 27, 2025 (GLOBE NEWSWIRE) -- Spectral Medical Inc. ("Spectral” or the "Company”) (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic shock, ...
PathChat, a new AI model for pathology made by Modella AI, received breakthrough status in January. The device can digest ...
Larimar Therapeutics, Inc. (Nasdaq: LRMR) has announced significant progress in its nomlabofusp program for Friedreich’s ...
1d
Despite a dip in revenue, Allurion Technologies Inc (ALUR) showcases strategic advancements and a robust plan for future growth.
The Food and Drug Administration (FDA) has approved a new drug for treating urinary tract infections, the first such drug ...
The U.S. Food and Drug Administration on Wednesday approved Soleno Therapeutics' drug to treat a rare genetic disorder, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback